Approval · Notice of Compliance 22757 · 2019
SSP+: Notice of Compliance 22757
Issued September 19, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22757
- Date
- September 19, 2019
- Company
- Maco PharmaMouvaux, Nord-Pas-De-Calais, France
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- POTASSIUM CHLORIDE 0.37 G per L
- SODIUM PHOSPHATE MONOBASIC 1.05 G per L
- SODIUM CHLORIDE 4.05 G per L
- SODIUM ACETATE TRIHYDRATE 4.42 G per L
- SODIUM PHOSPHATE DIBASIC 3.05 G per L
- MAGNESIUM CHLORIDE HEXAHYDRATE 0.3 G per L
- SODIUM CITRATE DIHYDRATE 3.18 G per L
- WATER 1,000 ML per L